Interferon-α for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies

Digestive Diseases and Sciences

Volumn 48, Issue 8, 2003, Pages 1654-1657

  Akuta, Norio ^a   Suzuki, Fumitaka ^a   Tsubota, Akihito ^a   Suzuki, Yoshiyuki ^a   Someya, Takashi ^a   Kobayashi, Masahiro ^a   Saitoh, Satoshi ^a   Arase, Yasuji ^a   Ikeda, Kenji ^a   Miyakawa, Yuzo ^b   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

^b Miyakawa Memorial Research Foundation   (Japan)

Author keywords

Acute hepatitis; Hepatitis C virus; Interferon therapy; Reinfection; Viral dynamics

Indexed keywords

ALCOHOL; ALPHA INTERFERON;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER HISTOLOGY; MALE; MICROWAVE IRRADIATION; PATIENT; PRIORITY JOURNAL; REINFECTION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERFERON-ALPHA; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RECURRENCE; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0042200296     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024796630509     Document Type: Article

References (22)

1. Jarvis LM, Watson HG, McOmish F, Peutherer JF, Ludlam CA, Simmonds P: Frequent reinfection and reactivation of hepatitis C virus genotypes in multitrasfused hemophiliacs. J Infect Dis 170:1018-1022, 1994
2. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, Farci P. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388-390, 1994
3. Zhang S, Hui Z, Li H, Qi Z, Widell A: Dynamic changes in hepatitis C virus genotypes and sequence patterns in plasma donors exposed to reinfection. J Med Virol 63:228-236, 2001
4. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ: The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 327:1899-1905, 1992
5. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, Di Bisceglie A, Hoofnagle J, Shih JW, Kaslow R, Ness P, Alter HJ: Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334:1691-1696, 1996
6. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, Szmuness W, Chen KP: Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 146:198-204, 1982
7. Stevens CE, Neurath RA, Beasley RP, Szmuness W: HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 3:237-241, 1979
8. Lee SD, Hwang SJ, Lu RH, Lai KH, Tsai YT, Lo KJ: Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis. J Infect Dis 163:1354-1357, 1991
9. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH: Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140, 1992
10. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Hejjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al-Rasheed AM, Lin M, Simmonds P: Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32:884-892, 1994
11. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspe G: Immunity in hepatitis C infection. J Infect Dis 165:438-443, 1992
12. Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ: A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 21:831-836, 1994
13. Takano S, Satomura Y, Omata M: Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group. Gastroenterology 107:805-811, 1994
14. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T: Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16:293-299, 1992
15. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, Fontanges T, Albrecht J, Meschievitz C, Trepo C: Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101:497-502, 1991
16. Davis GL, Lau JY: Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 26:122S-127S, 1997
17. Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825-832, 1997
18. Lopez-Labrador FX, Ampurdanes S, Gimenez-Barcons M, Guilera M, Costa J, De Anta MTJ, Sanchez-Tapias JM, Saiz JC: Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology 29:897-903, 1999
19. Pawlotsky JM, Pellerin M, Bouvier M, Roudot-Thoraval F, Germanidis G, Bastie A, Darthuy F, Remire J, Soussy CJ, Dhumeaux D: Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol 54:256-264, 1998
20. Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Sone Y, Kinoshita M, Hamada T: Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol 26:6-13, 1997
21. Neumann AU, Lam NP, Dabari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282:103-107, 1998
22. Neumann AU, Lam NP, Dabari H, Davidian M, Wiley TE, Mika BP, Perelson AS, Layden TJ: Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. J Infect Dis 182:28-35, 2000